The AMA adopted new AI policies in a bid to ensure that the technology supports evidence-based medicine, bolsters patient care and serves under a physician’s oversight, instead of replacing their ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results